U.S. SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                  FORM 10-QSB/A


(Mark One)

   [x]      Quarterly report under Section 13, or 15 (d) of the Securities
            Exchange Act of 1934

                 For the quarterly period ended January 31, 2004

   [ ]      Transition report under Section 13 or 15 (d) of the Exchange Act

               For the transition period from __________ to______


                         Commission file number 33-16335


                                   MALEX, INC.
       (Exact Name of Small Business Issuer as Specified in Its Charter)


                Delaware                                    75-2235008
   (State or Other Jurisdiction of                      (I.R.S. Employer
    Incorporation or Organization)                     Identification No.)

                18170 Hillcrest, Suite 100, Dallas, Texas, 75252
                    (Address of Principal Executive Offices)

                                 (972) 612 1400
                (Issuer's Telephone Number, Including Area Code)



              (Former Name, Former Address and Former Fiscal Year,
                          if Changed Since Last Report)



       Check whether the issuer:  (1) filed all reports  required to be filed by
Section 13 or 15(d) of the  Exchange  Act during the past 12 months (or for such
shorter period that the  registrant was required to file such reports),  and (2)
has been subject to such filing requirements for past 90 days. Yes No

                     APPLICABLE ONLY TO ISSUERS INVOLVED IN
                        BANKRUPTCY PROCEEDINGS DURING THE
                              PRECEDING FIVE YEARS

       Check whether the registrant  filed all documents and reports required to
be filed by Section 12, 13, or 15 (d) of the Exchange Act after the distribution
of securities under a plan confirmed by a court. Yes No

                      APPLICABLE ONLY TO CORPORATE ISSUERS

       State the number of shares outstanding of each of the issuer's classes of
common equity, as of the latest practicable date: 8,416,000

<PAGE>

                                   MALEX, INC.



                                    I N D E X



                                                                       Page No.

Part I         FINANCIAL INFORMATION:

          Item 1.   Balance Sheets                                        3

                    Statements of Operations                              4

                    Statements of Cash Flows                              5

                    Notes to Financial Statements (unaudited)             6

          Item 2.   Management's Discussion and Analysis of Financial
                    Condition and Results of Operations                   6

Part II   OTHER INFORMATION                                               7





                                        2
<PAGE>

                                   MALEX, INC.
                          (a development stage company)

                          PART I. FINANCIAL INFORMATION


                            CONDENSED BALANCE SHEETS

                                   (Unaudited)

                                     ASSETS

                                     January 31, 2005     April 30, 2004
                                        (Unaudited)         (Audited)


  Cash                                   $        3         $        3

Total Assets                             $        3         $        3


                      LIABILITIES AND STOCKHOLDERS' EQUITY


Current Liabilities                      $    6,950         $    6,000

Stockholders' Equity:
  Common stock (number of
  shares authorized 75,000,000,
  issued and outstanding
  8,400,000 shares, par value
  $.00002/sh)                                   168                 168

Additional paid in capital                    2,097               2,097

Deficit accumulated during
   the development stage                     (9,212)             (8,262)
Stockholders Equity                          (6,947)             (5,997)

Total Liabilities &
Stockholders' Equity                     $        3         $         3


   The accompanying notes are an integral part of these financial statements.

                                        3
<PAGE>

                                   MALEX, INC.
                          (a development stage company)

                             STATEMENTS OF OPERATION

                                   (Unaudited)


                            Three Months Ended    Three Months Ended
                                January 31,          October 31,
                                   2005                  2004


Income                         $      --             $      --


Expenses - General and
  Administrative               $      --             $       950

Net Income (Loss)              $      --             $      (950)

Earnings per common share*               *                     *

*(less than $0.001 per
  share)

Weighted average number of
  shares outstanding             8,416,000             8,416,000




                                        4
<PAGE>

                                   MALEX, INC.
                          (a development stage company)

                             STATEMENTS OF OPERATION

                                   (Unaudited)


                              Nine Months Ended    Nine Months Ended
                                 October 31,          October 31,
                                    2005                 2004


Income                          $      --            $      --


Expenses - General and
  Administrative                $       950          $       950

Net Income (Loss)               $      (950)         $      (950)

Earnings per common share*                *                    *

*(less than $0.001 per
  share)

Weighted average number of
  shares outstanding              8,416,000            8,416,000












        The accompanying notes are an integral part of these statements.

                                        5
<PAGE>

                                   MALEX, INC.
                          (a development stage company)

                            STATEMENTS OF CASH FLOWS

                                              Nine Months        Nine Months
                                                Ended              Ended
                                           January 31, 2005   January 31, 2004


CASH FLOWS FROM OPERATING ACTIVITIES:
  Net income (loss)                           $     (950)        $     (950)

ADJUSTMENTS TO RECONCILE NET GAIN (LOSS) TO
  NET CASH FROM OPERATING ACTIVITIES:
  Accounts payable and accrued expenses              950                950

  Net cash used by operating activities             --                 --

CASH FLOW FROM INVESTING ACTIVITIES:
     Net cash used by investing activities          --                 --

CASH FLOW FROM FINANCING ACTIVITIES:
  Net cash provided by financing activities         --                 --




NET INCREASE (DECREASE) IN CASH                     --                 --

BEGINNING CASH BALANCE                                 3                  3

CASH BALANCE AT END OF PERIOD                 $        3         $        3





   The accompanying notes are an integral part of these financial statements.

                                        6
<PAGE>

                          NOTES TO FINANCIAL STATEMENTS
                                   (UNAUDITED)

Item 1.   Financial Statements

The accompanying unaudited financial statements have been prepared in accordance
with the instructions to Form 10-Q and do not include all of the information and
footnotes  required by generally  accepted  accounting  principles  for complete
financial statements.

In the opinion of management,  all adjustments  (consisting of normal  recurring
accruals) considered necessary for a fair presentation have been included. These
statements should be read in conjunction with the audited  financial  statements
and notes thereto  included in the  Registrant's  Form 10-KSB for the year ended
April 30, 2004.

Item  2.    Management Discussion and Analysis of Financial Condition
and Results of Operations

The  period  ended  January  31,  2005  showed a loss of  $(950)  compared  with
$(950)for the previous year.

Registrant has no operations or  substantial  assets and intends to seek out and
obtain  candidates with which it can merge or whose  operations or assets can be
acquired through the issuance of common stock and possibly debt.

It is the present expectation of the Management of Registrant that in connection
with any such merger or  acquisition of operations or assets that the Management
of Registrant  will be  transferred  to the new  controlling  shareholders.  The
Management of Registrant intends to negotiate covenants with any such company or
controlling  shareholders that it/they will maintain  Registrant's  registration
with the  Securities  and  Exchange  Commission,  comply  with the  terms of its
Articles of  Incorporation  and Bylaws in all respects,  maintain and promote an
orderly market in  Registrant's  Common Stock and otherwise  treat  Registrant's
shareholders fairly.

Liquidity and Capital Resources

Registrant  is a  development-stage  company and has not  conducted any business
operations as yet. The  Registrant's  cash resources and liquidity are extremely
limited.  The  Registrant  has no  assets  to use as  collateral  to  allow  the
Registrant to borrow,  and there is no available  external funding source. If no
combination  partner  can  be  found  within  twelve  months,   Registrant  will
experience  severe  cash flow  difficulties.  Registrant's  principal  needs for
capital are for  Securities  and  Exchange  Commission  reporting  requirements,
bookkeeping and professional fees.

Item 3.   Controls and Procedures

As of the  end of the  period  covered  by  this  quarterly  report,  our  Chief
Executive  Officer  and  Chief  Financial  Officer  (the  "Certifying  Officer")
conducted  evaluations of our  disclosure  controls and  procedures.  As defined
under Sections  13a-15(e) and 15d-15(e) of the  Securities  Exchange Act of 1934
Act,  as  amended  (the  "Exchange  Act")  the  term  "disclosure  controls  and
procedures"  means controls and other  procedures of an issuer that are designed
to ensure that information required to be disclosed by the issuer in the reports
that it  files  or  submits  under  the  Exchange  Act is  recorded,  processed,
summarized  and reported,  within the time periods  specified in the SEC's rules
and forms.  Disclosure  controls and  procedures  include,  without  limitation,
controls  and  procedures  designed  to ensure that  information  required to be
disclosed  by an  issuer  in the  reports  that it files or  submits  under  the
Exchange  Act is  accumulated  and  communicated  to the  issuer 's  management,
including the Certifying  Officer,  to allow timely decisions regarding required
disclosure.  Based on this evaluation, the Certifying Officer has concluded that
our disclosure  controls and  procedures  were effective to ensure that material
information is recorded, processed, summarized and reported by our management on
a timely  basis in order to comply  with our  disclosure  obligations  under the
Exchange Act, and the rules and regulations promulgated thereunder.

                                        7
<PAGE>

                           PART II. OTHER INFORMATION

PART II - OTHER INFORMATION



Item 6.   Exhibits and Reports on Form 8-K

           31(1) Certification of Chief Executive Officer Pursuant to
                 Rule 13a-14(a) or Rule 15d-14(a).

           31(2) Certification of Chief Financial Officer Pursuant to
                 Rule 13a-14(a) or Rule 15d-14(a).

           32(1) Certification  of  Chief  Executive  Officer  Pursuant  to Rule
                 13a-14(b) or Rule  15d-14(b)  and 18 U.S.C.  Section  1350,  as
                 Adopted  Pursuant to Section 906 of the  Sarbanes-Oxley  Act of
                 2002.

           32(2) Certification  of  Chief  Financial  Officer  Pursuant  to Rule
                 13a-14(b) or Rule  15d-14(b)  and 18 U.S.C.  Section  1350,  as
                 Adopted  Pursuant to Section 906 of the  Sarbanes-Oxley  Act of
                 2002.



                                   SIGNATURES


Pursuant  to the  requirements  of the  Securities  Exchange  Act of  1934,  the
Registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereto duly authorized.



                              MALEX, INC.
                              (Registrant)



                            By: /s/ Daniel Wettreich
                              --------------------------
                              DANIEL WETTREICH, PRESIDENT


Date: March 9, 2005



                                        8